×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

HTG Molecular Diagnostics Inc. (HTGM) NASDAQ

$0.48 - (-)

Market Cap: -

As of 06/14/23 12:00 AM EDT. Market closed.

(HTGM)

HTG Molecular Diagnostics Inc. (HTGM)
NASDAQ

$0.48
- (-)

Market Cap: -

As of 06/14/23 12:00 AM EDT. Market closed.

Add to Portfolio

about htg molecular diagnostics: headquartered in tucson, arizona, htg's mission is to empower precision medicine at the local level. in 2013 the company commercialized its htg edge instrument platform and a portfolio of rna assays that leverage htg's proprietary nuclease protection chemistry. htg's product offerings have since expanded to include its htg edgeseq product line, which automates ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
CEO
John Lubniewski
Full Time Employees
77
URL
Address
3430 E Global Loop, Arizona, Tucson, 85706-5009.
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
CEO
John Lubniewski
Full Time Employees
77
Address
3430 E Global Loop, Arizona, Tucson, 85706-5009.
PRICE CHART FOR HTG MOLECULAR DIAGNOSTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.54
Previous Close
$0.48
Days Range
$0.46 - $0.61
52 week range
- - -
Volume
773,040
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
2,214,233
Open
$0.54
Previous Close
$0.48
Days Range
$0.46 - $0.61
52 week range
- - -
Volume
773,040
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
2,214,233
FINANCIAL STATEMENTS FOR HTG MOLECULAR DIAGNOSTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR HTG MOLECULAR DIAGNOSTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Barat StephenSenior VP of TherapeuticsJun 08, 2023 Sale$0.80888710421Jun 09, 2023, 08:11 PM
Barat StephenSenior VP of TherapeuticsMar 31, 2023 Option Exercise$2.70521401,309Apr 07, 2023, 04:16 PM
Lawson ByronSVP/Chief Commercial OfficerDec 09, 2022 Option Exercise$0.431,0004256,033Dec 13, 2022, 05:41 PM
Lubniewski John LPresident & CEODec 09, 2022 Option Exercise$0.431,00042514,133Dec 13, 2022, 05:40 PM
McMeans Shaun DSVP, Finance & Admin. & CFODec 09, 2022 Option Exercise$0.431,00042510,570Dec 13, 2022, 05:39 PM
Godlewski Laura LeeSVP Finance & AdministrationDec 09, 2022 Option Exercise$0.431,0004254,904Dec 13, 2022, 05:38 PM
Lawson ByronSVP/Chief Commercial OfficerJun 30, 2022 Option Exercise$1.0323245,033Jul 01, 2022, 05:42 PM
McMeans Shaun DSVP, Finance & Admin. & CFOJun 30, 2022 Option Exercise$1.0329309,570Jul 01, 2022, 05:41 PM
Lubniewski John LPresident & CEOJun 30, 2022 Option Exercise$1.03616313,133Jul 01, 2022, 05:39 PM
Godlewski Laura LeeSVP Finance & AdministrationJun 10, 2022 Option Exercise$0.481,0004763,904Jun 15, 2022, 04:33 PM
McMeans Shaun DSVP, Finance & Admin. & CFOJun 10, 2022 Option Exercise$0.481,0004769,599Jun 15, 2022, 04:32 PM
Lubniewski John LPresident & CEOJun 10, 2022 Option Exercise$0.481,00047613,194Jun 15, 2022, 04:32 PM
Lawson ByronSVP/Chief Commercial OfficerJun 10, 2022 Option Exercise$0.481,0004765,056Jun 15, 2022, 04:31 PM
Lawson ByronSVP/Chief Commercial OfficerMar 31, 2022 Option Exercise$1.3923324,056Apr 04, 2022, 04:30 PM
McMeans Shaun DSVP, Finance & Admin. & CFOMar 31, 2022 Option Exercise$1.3931438,599Apr 04, 2022, 04:27 PM
Lubniewski John LPresident & CEOMar 31, 2022 Option Exercise$1.39628612,194Apr 04, 2022, 04:23 PM
Lawson ByronSVP/Chief Commercial OfficerDec 31, 2021 Option Exercise$5.42241304,079Jan 04, 2022, 04:40 PM
Lawson ByronSVP/Chief Commercial OfficerDec 10, 2021 Option Exercise$3.568963,1914,103Dec 15, 2021, 05:06 PM
Godlewski Laura LeeVP Finance, Prin Acct OffrDec 10, 2021 Option Exercise$3.561,0003,5622,904Dec 15, 2021, 05:03 PM
McMeans Shaun DSVP, Finance & Admin. & CFODec 10, 2021 Option Exercise$3.565201,8528,661Dec 15, 2021, 04:57 PM
Lubniewski John LPresident & CEODec 10, 2021 Option Exercise$3.561,0003,56212,318Dec 15, 2021, 04:55 PM
McMeans Shaun DSVP, Finance & Admin. & CFOSep 30, 2021 Option Exercise$5.71311778,141Oct 04, 2021, 04:39 PM
Lubniewski John LPresident & CEOSep 30, 2021 Option Exercise$5.716235411,318Oct 04, 2021, 04:37 PM
Lawson ByronSVP/Chief Commercial OfficerSep 30, 2021 Option Exercise$5.71241373,207Oct 04, 2021, 04:36 PM
Lawson ByronSVP/Chief Commercial OfficerJun 30, 2021 Option Exercise$5.81241393,231Jul 02, 2021, 07:18 PM
McMeans Shaun DSVP, Finance & Admin. & CFOJun 30, 2021 Option Exercise$5.81311808,172Jul 02, 2021, 07:10 PM
Lubniewski John LPresident & CEOJun 30, 2021 Option Exercise$5.816236011,380Jul 02, 2021, 07:06 PM
Godlewski Laura LeeVP Finance, Prin Acct OffrJun 10, 2021 Option Exercise$3.926722,6331,904Jun 14, 2021, 08:32 PM
Lawson ByronSVP/Chief Commercial OfficerJun 10, 2021 Option Exercise$3.923541,3873,255Jun 14, 2021, 08:30 PM
Lubniewski John LPresident & CEOJun 10, 2021 Option Exercise$3.921,0003,91811,442Jun 14, 2021, 08:21 PM
Lawson ByronSVP/Chief Commercial OfficerMar 31, 2021 Option Exercise$5.47281532,901Apr 02, 2021, 05:49 PM
McMeans Shaun DSVP, Finance & Admin. & CFODec 31, 2020 Option Exercise$4.79311487,771Jan 04, 2021, 06:00 PM
Lawson ByronSVP/Chief Commercial OfficerDec 31, 2020 Option Exercise$4.79241152,929Jan 04, 2021, 05:57 PM
Lubniewski John LPresident & CEODec 31, 2020 Option Exercise$4.796229710,504Jan 04, 2021, 05:55 PM
JOHNSON TIM BExecutive ChairmanDec 31, 2020 Option Exercise$4.7910952216,738Jan 04, 2021, 05:53 PM
Godlewski Laura LeeVP Finance, Prin Acct OffrDec 10, 2020 Option Exercise$4.87663211,232Dec 16, 2020, 06:14 PM
Lawson ByronSVP/Chief Commercial OfficerDec 10, 2020 Option Exercise$4.87663212,953Dec 16, 2020, 06:13 PM
McMeans Shaun DSVP, Finance & Admin. & CFODec 10, 2020 Option Exercise$4.87663217,802Dec 16, 2020, 06:12 PM
Lubniewski John LPresident & CEODec 10, 2020 Option Exercise$4.876632110,566Dec 16, 2020, 06:10 PM
JOHNSON TIM BExecutive ChairmanDec 10, 2020 Option Exercise$4.873416616,847Dec 16, 2020, 06:08 PM
Lawson ByronSVP/Chief Commercial OfficerSep 30, 2020 Option Exercise$0.3335011643,333Oct 02, 2020, 05:47 PM
McMeans Shaun DSVP, Finance & Admin. & CFOSep 30, 2020 Option Exercise$0.33461152116,080Oct 02, 2020, 05:39 PM
Lubniewski John LPresident & CEOSep 30, 2020 Option Exercise$0.33921304157,534Oct 02, 2020, 05:37 PM
JOHNSON TIM BExecutive ChairmanSep 30, 2020 Option Exercise$0.331,630538252,217Oct 02, 2020, 05:35 PM
Lawson ByronSVP/Chief Commercial OfficerJun 30, 2020 Option Exercise$0.7235025243,683Jul 02, 2020, 05:23 PM
Lubniewski John LPresident & CEOJun 30, 2020 Option Exercise$0.72921663158,455Jul 02, 2020, 05:20 PM
McMeans Shaun DSVP, Finance & Admin. & CFOJun 30, 2020 Option Exercise$0.72447322116,541Jul 02, 2020, 05:16 PM
JOHNSON TIM BExecutive ChairmanJun 30, 2020 Option Exercise$0.721,6301,174253,847Jul 02, 2020, 05:09 PM
Lawson ByronSVP/Chief Commercial OfficerJun 10, 2020 Option Exercise$0.551,00055344,033Jun 15, 2020, 06:21 PM
Godlewski Laura LeeVP Finance, Prin Acct OffrJun 10, 2020 Option Exercise$0.551,00055317,506Jun 15, 2020, 06:19 PM
McMeans Shaun DSVP, Finance & Admin. & CFOJun 10, 2020 Option Exercise$0.551,000553116,988Jun 15, 2020, 06:17 PM
JOHNSON TIM BExecutive ChairmanJun 10, 2020 Option Exercise$0.55905500255,477Jun 15, 2020, 06:15 PM
JOHNSON TIM BExecutive ChairmanDec 10, 2019 Option Exercise$0.57701396254,572Jun 15, 2020, 06:15 PM
JOHNSON TIM BExecutive ChairmanJun 10, 2019 Option Exercise$1.577611,197253,871Jun 15, 2020, 06:15 PM
Lubniewski John LPresident & CEOJun 10, 2020 Option Exercise$0.551,000553159,376Jun 15, 2020, 06:13 PM
Lawson ByronSVP/Chief Commercial OfficerMar 31, 2020 Option Exercise$0.3341613743,033Apr 02, 2020, 04:14 PM
JOHNSON TIM BExecutive ChairmanMar 31, 2020 Option Exercise$0.331,630538253,110Apr 02, 2020, 04:13 PM
McMeans Shaun DSVP, Finance & Admin. & CFOMar 31, 2020 Option Exercise$0.33544180115,988Apr 02, 2020, 04:10 PM
Lubniewski John LPresident & CEOMar 31, 2020 Option Exercise$0.331,086358158,376Apr 02, 2020, 04:07 PM
JOHNSON TIM BExecutive ChairmanDec 31, 2019 Option Exercise$0.701,381967254,740Jan 02, 2020, 04:53 PM
JOHNSON TIM BExecutive ChairmanDec 26, 2019 Sale$0.725,7184,110256,121Jan 02, 2020, 04:53 PM
McMeans Shaun DSVP, Finance & Admin. & CFODec 31, 2019 Option Exercise$0.70461323116,532Jan 02, 2020, 04:52 PM
Lubniewski John LPresident & CEODec 31, 2019 Option Exercise$0.70921645159,462Jan 02, 2020, 04:50 PM
Godlewski Laura LeeVP Finance, Prin Acct OffrDec 10, 2019 Option Exercise$0.5770139616,506Dec 12, 2019, 05:42 PM
McMeans Shaun DSVP, Finance & Admin. & CFODec 10, 2019 Option Exercise$0.57701396116,993Dec 12, 2019, 05:36 PM
Lubniewski John LPresident & CEODec 10, 2019 Option Exercise$0.57701396160,383Dec 12, 2019, 05:32 PM
McMeans Shaun DSVP, Finance & Admin. & CFOSep 30, 2019 Option Exercise$0.66461304116,292Oct 02, 2019, 04:29 PM
Lubniewski John LPresident & CEOSep 30, 2019 Option Exercise$0.66921608159,682Oct 02, 2019, 04:27 PM
JOHNSON TIM BExecutive ChairmanSep 30, 2019 Option Exercise$0.661,381911261,839Oct 02, 2019, 04:24 PM
McMeans Shaun DSVP, Finance & Admin. & CFOJul 01, 2019 Option Exercise$1.66461765116,753Jul 03, 2019, 04:20 PM
Lubniewski John LPresident & CEOJul 01, 2019 Option Exercise$1.669211,529160,603Jul 03, 2019, 04:19 PM
JOHNSON TIM BDirectorJul 01, 2019 Option Exercise$1.661,3812,292263,220Jul 03, 2019, 04:18 PM
Godlewski Laura LeeVP of Accounting and ReportingJun 10, 2019 Option Exercise$1.577611,19715,805Jun 13, 2019, 09:34 AM
McMeans Shaun DSVP, Finance & Admin. & CFOJun 10, 2019 Option Exercise$1.577611,197117,214Jun 13, 2019, 09:33 AM
Lubniewski John LPresident & CEOJun 10, 2019 Option Exercise$1.577611,197161,524Jun 13, 2019, 09:31 AM
JOHNSON TIM BDirectorMay 24, 2019 Option Exercise$2.307,50017,250264,601May 29, 2019, 04:50 PM
McMeans Shaun DSVP, Finance & Admin. & CFOApr 01, 2019 Option Exercise$2.504471,118116,453Apr 01, 2019, 08:02 PM
JOHNSON TIM BDirectorApr 01, 2019 Option Exercise$2.501,3813,453257,101Apr 01, 2019, 07:57 PM
Lubniewski John LPresident & CEOApr 01, 2019 Option Exercise$2.509092,273160,763Apr 01, 2019, 07:55 PM
McMeans Shaun DSVP, Finance & Admin. & CFODec 31, 2018 Option Exercise$2.544611,171116,900Jan 02, 2019, 09:41 PM
Lubniewski John LPresident & COODec 31, 2018 Option Exercise$2.549212,339161,672Jan 02, 2019, 09:38 PM
JOHNSON TIM BCEODec 31, 2018 Option Exercise$2.541,3813,508258,482Jan 02, 2019, 09:37 PM
McMeans Shaun DSVP, Finance & Admin. & CFODec 07, 2018 Option Exercise$1.577351,156117,361Dec 17, 2018, 04:35 PM
Lubniewski John LPresident & COODec 07, 2018 Option Exercise$1.577351,156162,593Dec 17, 2018, 04:34 PM
JOHNSON TIM BCEODec 07, 2018 Option Exercise$1.577351,156259,863Dec 17, 2018, 04:31 PM
JOHNSON TIM BCEOOct 01, 2018 Option Exercise$4.521,3816,242259,128Oct 02, 2018, 05:37 PM
Lubniewski John LPresident & COOOct 01, 2018 Option Exercise$4.529214,163161,858Oct 02, 2018, 05:34 PM
McMeans Shaun DSVP, Finance & Admin. & CFOOct 01, 2018 Option Exercise$4.524612,084116,626Oct 02, 2018, 05:31 PM
HANHAM ANNDirectorSep 11, 2018 Option Exercise$4.342,3049,9994,804Sep 12, 2018, 12:00 AM
Lubniewski John LPresident & COOJun 08, 2018 Option Exercise$1.577881,239112,779Jun 14, 2018, 06:48 PM
Roche Patrick C.SVP Medical/Scientific AffairsJun 08, 2018 Option Exercise$1.577881,23943,421Jun 14, 2018, 06:46 PM
JOHNSON TIM BCEOJun 08, 2018 Option Exercise$1.577881,239185,509Jun 14, 2018, 06:43 PM
McMeans Shaun DSVP, Finance & Admin. & CFOJun 08, 2018 Option Exercise$1.576751,06192,087Jun 14, 2018, 06:41 PM
JOHNSON TIM BPresident & CEOJan 29, 2018 Option Exercise$3.8434,769133,513184,721Jan 31, 2018, 04:54 PM
Roche Patrick C.SVP Research & DevelopmentDec 08, 2017 Option Exercise$1.618181,31442,633Dec 15, 2017, 05:12 PM
JOHNSON TIM BPresident & CEODec 08, 2017 Option Exercise$1.618181,314101,432Dec 15, 2017, 05:11 PM
Lubniewski John LChief Business OfficerDec 08, 2017 Option Exercise$1.618181,31448,508Dec 15, 2017, 05:10 PM
McMeans Shaun DVP, Finance & Admin. & CFODec 08, 2017 Option Exercise$1.618181,31443,121Dec 15, 2017, 05:08 PM
Gordon Debra AV.P. and Chief Legal CounselDec 08, 2017 Option Exercise$1.618181,31442,833Dec 15, 2017, 05:06 PM
McMeans Shaun DVP, Finance & Admin. & CFODec 01, 2017 Sale$2.119451,99242,303Dec 01, 2017, 04:22 PM
George Harry A.DirectorNov 29, 2017 Option Exercise$2.144,0308,62434,030Nov 30, 2017, 04:52 PM
George Harry A.DirectorNov 28, 2017 Option Exercise$2.197,50016,42530,000Nov 29, 2017, 04:40 PM
George Harry A.DirectorNov 27, 2017 Option Exercise$2.217,50016,57522,500Nov 29, 2017, 04:40 PM
Gordon Debra AV.P. and Chief Legal CounselNov 22, 2017 Option Exercise$2.251,1112,50042,015Nov 27, 2017, 04:35 PM
George Harry A.DirectorNov 24, 2017 Option Exercise$2.207,50016,50015,000Nov 27, 2017, 04:34 PM
George Harry A.DirectorNov 22, 2017 Option Exercise$2.257,50016,8757,500Nov 27, 2017, 04:34 PM
McMeans Shaun DVP, Finance & Admin. & CFONov 01, 2017 Sale$2.269452,13643,248Nov 03, 2017, 04:18 PM
McMeans Shaun DVP, Finance & Admin. & CFOOct 16, 2017 Sale$2.279462,14844,193Oct 18, 2017, 04:15 PM
McMeans Shaun DVP, Finance & Admin. & CFOAug 24, 2017 Option Exercise$1.992,5004,97545,139Aug 28, 2017, 04:30 PM
Novo Holdings A/S10% OwnerAug 25, 2017 Sale$1.75720,2141,260,5910Aug 25, 2017, 07:17 PM
Novo Holdings A/S10% OwnerAug 24, 2017 Sale$1.91382,437729,919720,214Aug 25, 2017, 07:17 PM
Novo Holdings A/S10% OwnerAug 23, 2017 Sale$2.0247,16295,4751,102,651Aug 25, 2017, 07:17 PM
LAFRANCE JAMES TDirectorAug 23, 2017 Option Exercise$2.057,50015,3757,500Aug 24, 2017, 05:14 PM
HARDISON DON MDirectorAug 23, 2017 Option Exercise$2.057,50015,3757,500Aug 24, 2017, 05:07 PM
JOHNSON TIM BPresident & CEOAug 23, 2017 Option Exercise$2.057,50015,375100,614Aug 24, 2017, 05:06 PM
Gordon Debra AV.P. and Chief Legal CounselAug 23, 2017 Option Exercise$2.051,0002,05040,904Aug 24, 2017, 04:57 PM
Novo Holdings A/S10% OwnerAug 22, 2017 Sale$2.0112,64125,4121,199,599Aug 22, 2017, 07:25 PM
Novo Holdings A/S10% OwnerAug 21, 2017 Sale$2.0212,84525,9761,212,240Aug 22, 2017, 07:25 PM
Novo Holdings A/S10% OwnerAug 18, 2017 Sale$2.1055,100115,6001,225,085Aug 22, 2017, 07:25 PM
Gordon Debra AV.P. and Chief Legal CounselJun 15, 2017 Option Exercise$1.796201,11239,904Jul 17, 2017, 06:45 PM
JOHNSON TIM BPresident & CEOJun 15, 2017 Option Exercise$1.799011,61693,114Jul 17, 2017, 06:42 PM
McMeans Shaun DVP, Finance & Admin. & CFOJun 15, 2017 Option Exercise$1.799011,61642,639Jul 17, 2017, 06:41 PM
Lubniewski John LChief Business OfficerJun 15, 2017 Option Exercise$1.799011,61647,690Jul 17, 2017, 06:39 PM
Roche Patrick C.SVP Research & DevelopmentJun 15, 2017 Option Exercise$1.799011,61641,815Jul 17, 2017, 06:37 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerMar 27, 2017 Sale$10.15300,0003,045,180792,781Mar 30, 2017, 04:11 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerMar 27, 2017 Sale$10.15300,0003,045,180792,781Mar 29, 2017, 04:04 PM
Roche Patrick C.SVP Research & DevelopmentDec 09, 2016 Option Exercise$1.838341,52440,914Dec 14, 2016, 04:24 PM
McMeans Shaun DVP, Finance & Admin. & CFODec 09, 2016 Option Exercise$1.838341,52441,738Dec 14, 2016, 04:22 PM
Lubniewski John LChief Business OfficerDec 09, 2016 Option Exercise$1.838341,52446,789Dec 14, 2016, 04:21 PM
JOHNSON TIM BPresident & CEODec 09, 2016 Option Exercise$1.838341,52492,213Dec 14, 2016, 04:19 PM
Gordon Debra AV.P. and Chief Legal CounselDec 09, 2016 Option Exercise$1.838341,52439,284Dec 14, 2016, 04:17 PM
JOHNSON TIM BPresident & CEOJun 10, 2016 Option Exercise$2.546081,54551,379Jun 14, 2016, 07:22 PM
Roche Patrick C.SVP Research & DevelopmentJun 10, 2016 Option Exercise$2.549282,35920,080Jun 14, 2016, 07:21 PM
Lubniewski John LChief Business OfficerJun 10, 2016 Option Exercise$2.549282,35925,955Jun 14, 2016, 07:20 PM
McMeans Shaun DVP, Finance & Admin. & CFOJun 10, 2016 Option Exercise$2.549282,35920,904Jun 14, 2016, 07:19 PM
Gordon Debra AV.P. and Chief Legal CounselJun 10, 2016 Option Exercise$2.549282,35918,450Jun 14, 2016, 07:17 PM
Lubniewski John LChief Business OfficerApr 01, 2016 Sale$2.897092,04825,114Apr 05, 2016, 05:33 PM
Lubniewski John LChief Business OfficerApr 04, 2016 Sale$2.928725425,027Apr 05, 2016, 05:33 PM
McMeans Shaun DVP, Finance & Admin. & CFOApr 04, 2016 Sale$2.9217551219,976Apr 05, 2016, 05:32 PM
McMeans Shaun DVP, Finance & Admin. & CFOApr 01, 2016 Sale$2.891,4264,11920,151Apr 05, 2016, 05:32 PM
JOHNSON TIM BPresident & CEOApr 04, 2016 Sale$2.925381,57350,771Apr 05, 2016, 05:31 PM
JOHNSON TIM BPresident & CEOApr 01, 2016 Sale$2.894,37612,64151,309Apr 05, 2016, 05:31 PM
Gordon Debra AV.P. and Chief Legal CounselApr 04, 2016 Sale$2.9218353517,522Apr 05, 2016, 05:28 PM
Gordon Debra AV.P. and Chief Legal CounselApr 01, 2016 Sale$2.891,4894,30117,705Apr 05, 2016, 05:28 PM
Roche Patrick C.SVP Research & DevelopmentMar 10, 2016 Sale$2.491,2983,23223,783Mar 14, 2016, 08:44 PM
Roche Patrick C.SVP Research & DevelopmentMar 14, 2016 Sale$2.1911124319,152Mar 14, 2016, 08:44 PM
Roche Patrick C.SVP Research & DevelopmentMar 11, 2016 Sale$2.364,52010,64619,263Mar 14, 2016, 08:44 PM
McMeans Shaun DVP, Finance & Admin. & CFOMar 14, 2016 Sale$2.1910923821,577Mar 14, 2016, 08:43 PM
McMeans Shaun DVP, Finance & Admin. & CFOMar 11, 2016 Sale$2.364,30510,14021,686Mar 14, 2016, 08:43 PM
McMeans Shaun DVP, Finance & Admin. & CFOMar 10, 2016 Sale$2.491,2373,08125,991Mar 14, 2016, 08:43 PM
Lubniewski John LChief Business OfficerMar 10, 2016 Sale$2.491,5123,76531,200Mar 14, 2016, 08:41 PM
Lubniewski John LChief Business OfficerMar 14, 2016 Sale$2.1911324725,823Mar 14, 2016, 08:41 PM
Lubniewski John LChief Business OfficerMar 11, 2016 Sale$2.365,26412,39925,936Mar 14, 2016, 08:41 PM
JOHNSON TIM BPresident & CEOMar 14, 2016 Sale$2.1912527355,685Mar 14, 2016, 08:40 PM
JOHNSON TIM BPresident & CEOMar 11, 2016 Sale$2.368,15419,20655,810Mar 14, 2016, 08:40 PM
JOHNSON TIM BPresident & CEOMar 10, 2016 Sale$2.492,3425,83263,964Mar 14, 2016, 08:40 PM
Gordon Debra AV.P. and Chief Legal CounselMar 14, 2016 Sale$2.1910923819,194Mar 14, 2016, 08:39 PM
Gordon Debra AV.P. and Chief Legal CounselMar 11, 2016 Sale$2.364,2159,92819,303Mar 14, 2016, 08:39 PM
Gordon Debra AV.P. and Chief Legal CounselMar 10, 2016 Sale$2.491,2113,01623,518Mar 14, 2016, 08:39 PM
McMeans Shaun DVP, Finance & Admin. & CFOMar 09, 2016 Sale$2.693,3258,93327,228Mar 09, 2016, 08:29 PM
Roche Patrick C.SVP Research & DevelopmentMar 09, 2016 Sale$2.693,4919,37925,081Mar 09, 2016, 08:28 PM
Lubniewski John LChief Business OfficerMar 09, 2016 Sale$2.694,06710,92732,712Mar 09, 2016, 08:26 PM
JOHNSON TIM BPresident & CEOMar 09, 2016 Sale$2.696,29916,92466,306Mar 09, 2016, 08:25 PM
Gordon Debra AV.P. and Chief Legal CounselMar 09, 2016 Sale$2.693,2568,74824,729Mar 09, 2016, 08:24 PM
McMeans Shaun DVP, Finance & Admin. & CFODec 10, 2015 Option Exercise$4.781,0465,0009,532Dec 14, 2015, 06:20 PM
Gordon Debra AV.P. and Chief Legal CounselDec 10, 2015 Option Exercise$4.781,0465,0007,402Dec 14, 2015, 06:19 PM
JOHNSON TIM BPresident & CEODec 10, 2015 Option Exercise$4.782,09210,00028,810Dec 14, 2015, 06:18 PM
JOHNSON TIM BPresident & CEOAug 24, 2015 Buy$5.341,0005,34111,718Aug 25, 2015, 05:12 PM
Gordon Debra AV.P. and Chief Legal CounselAug 24, 2015 Buy$5.161,0005,1601,356Aug 24, 2015, 04:16 PM
Roche Patrick C.SVP Research & DevelopmentAug 18, 2015 Buy$5.766,50037,4356,500Aug 19, 2015, 05:11 PM
JOHNSON TIM BPresident & CEOAug 12, 2015 Buy$7.525,00037,62310,718Aug 13, 2015, 04:25 PM
McMeans Shaun DVP, Finance & Admin. & CFOAug 12, 2015 Buy$7.5010,40078,0003,486Aug 12, 2015, 08:10 PM
Lubniewski John LChief Business OfficerAug 11, 2015 Buy$7.675,00038,3488,571Aug 12, 2015, 02:21 PM
Merck Capital Ventures LLC10% OwnerMay 11, 2015 Option Exercise$14.0055,377775,278536,432May 13, 2015, 04:36 PM
Merck Capital Ventures LLC10% OwnerMay 11, 2015 Buy$14.00167,3432,342,802756,704May 13, 2015, 04:36 PM
Fletcher Spaght Ventures II LP10% OwnerMay 11, 2015 Option Exercise$14.0044,301620,214347,746May 13, 2015, 04:20 PM
Fletcher Spaght Ventures II LP10% OwnerMay 11, 2015 Buy$14.00102,4451,434,230518,595May 13, 2015, 04:20 PM
GLAXOSMITHKLINE PLC10% OwnerMay 11, 2015 Buy$14.00365,1065,111,484365,106May 13, 2015, 12:36 PM
Novo A/S10% OwnerMay 11, 2015 Buy$14.00365,1065,111,4841,280,185May 12, 2015, 05:32 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Barat StephenSenior VP of Therapeutics06/08/2023710
Barat StephenSenior VP of Therapeutics03/31/2023140
Lawson ByronSVP/Chief Commercial Officer12/09/2022425
Lubniewski John LPresident & CEO12/09/2022425
McMeans Shaun DSVP, Finance & Admin. & CFO12/09/2022425
Godlewski Laura LeeSVP Finance & Administration12/09/2022425
Lawson ByronSVP/Chief Commercial Officer06/30/202224
McMeans Shaun DSVP, Finance & Admin. & CFO06/30/202230
Lubniewski John LPresident & CEO06/30/202263
Godlewski Laura LeeSVP Finance & Administration06/10/2022476
McMeans Shaun DSVP, Finance & Admin. & CFO06/10/2022476
Lubniewski John LPresident & CEO06/10/2022476
Lawson ByronSVP/Chief Commercial Officer06/10/2022476
Lawson ByronSVP/Chief Commercial Officer03/31/202232
McMeans Shaun DSVP, Finance & Admin. & CFO03/31/202243
Lubniewski John LPresident & CEO03/31/202286
Lawson ByronSVP/Chief Commercial Officer12/31/2021130
Lawson ByronSVP/Chief Commercial Officer12/10/20213,191
Godlewski Laura LeeVP Finance, Prin Acct Offr12/10/20213,562
McMeans Shaun DSVP, Finance & Admin. & CFO12/10/20211,852
Lubniewski John LPresident & CEO12/10/20213,562
McMeans Shaun DSVP, Finance & Admin. & CFO09/30/2021177
Lubniewski John LPresident & CEO09/30/2021354
Lawson ByronSVP/Chief Commercial Officer09/30/2021137
Lawson ByronSVP/Chief Commercial Officer06/30/2021139
McMeans Shaun DSVP, Finance & Admin. & CFO06/30/2021180
Lubniewski John LPresident & CEO06/30/2021360
Godlewski Laura LeeVP Finance, Prin Acct Offr06/10/20212,633
Lawson ByronSVP/Chief Commercial Officer06/10/20211,387
Lubniewski John LPresident & CEO06/10/20213,918
Lawson ByronSVP/Chief Commercial Officer03/31/2021153
McMeans Shaun DSVP, Finance & Admin. & CFO12/31/2020148
Lawson ByronSVP/Chief Commercial Officer12/31/2020115
Lubniewski John LPresident & CEO12/31/2020297
JOHNSON TIM BExecutive Chairman12/31/2020522
Godlewski Laura LeeVP Finance, Prin Acct Offr12/10/2020321
Lawson ByronSVP/Chief Commercial Officer12/10/2020321
McMeans Shaun DSVP, Finance & Admin. & CFO12/10/2020321
Lubniewski John LPresident & CEO12/10/2020321
JOHNSON TIM BExecutive Chairman12/10/2020166
Lawson ByronSVP/Chief Commercial Officer09/30/2020116
McMeans Shaun DSVP, Finance & Admin. & CFO09/30/2020152
Lubniewski John LPresident & CEO09/30/2020304
JOHNSON TIM BExecutive Chairman09/30/2020538
Lawson ByronSVP/Chief Commercial Officer06/30/2020252
Lubniewski John LPresident & CEO06/30/2020663
McMeans Shaun DSVP, Finance & Admin. & CFO06/30/2020322
JOHNSON TIM BExecutive Chairman06/30/20201,174
Lawson ByronSVP/Chief Commercial Officer06/10/2020553
Godlewski Laura LeeVP Finance, Prin Acct Offr06/10/2020553
McMeans Shaun DSVP, Finance & Admin. & CFO06/10/2020553
JOHNSON TIM BExecutive Chairman06/10/2020500
JOHNSON TIM BExecutive Chairman12/10/2019396
JOHNSON TIM BExecutive Chairman06/10/20191,197
Lubniewski John LPresident & CEO06/10/2020553
Lawson ByronSVP/Chief Commercial Officer03/31/2020137
JOHNSON TIM BExecutive Chairman03/31/2020538
McMeans Shaun DSVP, Finance & Admin. & CFO03/31/2020180
Lubniewski John LPresident & CEO03/31/2020358
JOHNSON TIM BExecutive Chairman12/31/2019967
JOHNSON TIM BExecutive Chairman12/26/20194,110
McMeans Shaun DSVP, Finance & Admin. & CFO12/31/2019323
Lubniewski John LPresident & CEO12/31/2019645
Godlewski Laura LeeVP Finance, Prin Acct Offr12/10/2019396
McMeans Shaun DSVP, Finance & Admin. & CFO12/10/2019396
Lubniewski John LPresident & CEO12/10/2019396
McMeans Shaun DSVP, Finance & Admin. & CFO09/30/2019304
Lubniewski John LPresident & CEO09/30/2019608
JOHNSON TIM BExecutive Chairman09/30/2019911
McMeans Shaun DSVP, Finance & Admin. & CFO07/01/2019765
Lubniewski John LPresident & CEO07/01/20191,529
JOHNSON TIM BDirector07/01/20192,292
Godlewski Laura LeeVP of Accounting and Reporting06/10/20191,197
McMeans Shaun DSVP, Finance & Admin. & CFO06/10/20191,197
Lubniewski John LPresident & CEO06/10/20191,197
JOHNSON TIM BDirector05/24/201917,250
McMeans Shaun DSVP, Finance & Admin. & CFO04/01/20191,118
JOHNSON TIM BDirector04/01/20193,453
Lubniewski John LPresident & CEO04/01/20192,273
McMeans Shaun DSVP, Finance & Admin. & CFO12/31/20181,171
Lubniewski John LPresident & COO12/31/20182,339
JOHNSON TIM BCEO12/31/20183,508
McMeans Shaun DSVP, Finance & Admin. & CFO12/07/20181,156
Lubniewski John LPresident & COO12/07/20181,156
JOHNSON TIM BCEO12/07/20181,156
JOHNSON TIM BCEO10/01/20186,242
Lubniewski John LPresident & COO10/01/20184,163
McMeans Shaun DSVP, Finance & Admin. & CFO10/01/20182,084
HANHAM ANNDirector09/11/20189,999
Lubniewski John LPresident & COO06/08/20181,239
Roche Patrick C.SVP Medical/Scientific Affairs06/08/20181,239
JOHNSON TIM BCEO06/08/20181,239
McMeans Shaun DSVP, Finance & Admin. & CFO06/08/20181,061
JOHNSON TIM BPresident & CEO01/29/2018133,513
Roche Patrick C.SVP Research & Development12/08/20171,314
JOHNSON TIM BPresident & CEO12/08/20171,314
Lubniewski John LChief Business Officer12/08/20171,314
McMeans Shaun DVP, Finance & Admin. & CFO12/08/20171,314
Gordon Debra AV.P. and Chief Legal Counsel12/08/20171,314
McMeans Shaun DVP, Finance & Admin. & CFO12/01/20171,992
George Harry A.Director11/29/20178,624
George Harry A.Director11/28/201716,425
George Harry A.Director11/27/201716,575
Gordon Debra AV.P. and Chief Legal Counsel11/22/20172,500
George Harry A.Director11/24/201716,500
George Harry A.Director11/22/201716,875
McMeans Shaun DVP, Finance & Admin. & CFO11/01/20172,136
McMeans Shaun DVP, Finance & Admin. & CFO10/16/20172,148
McMeans Shaun DVP, Finance & Admin. & CFO08/24/20174,975
Novo Holdings A/S10% Owner08/25/20171,260,591
Novo Holdings A/S10% Owner08/24/2017729,919
Novo Holdings A/S10% Owner08/23/201795,475
LAFRANCE JAMES TDirector08/23/201715,375
HARDISON DON MDirector08/23/201715,375
JOHNSON TIM BPresident & CEO08/23/201715,375
Gordon Debra AV.P. and Chief Legal Counsel08/23/20172,050
Novo Holdings A/S10% Owner08/22/201725,412
Novo Holdings A/S10% Owner08/21/201725,976
Novo Holdings A/S10% Owner08/18/2017115,600
Gordon Debra AV.P. and Chief Legal Counsel06/15/20171,112
JOHNSON TIM BPresident & CEO06/15/20171,616
McMeans Shaun DVP, Finance & Admin. & CFO06/15/20171,616
Lubniewski John LChief Business Officer06/15/20171,616
Roche Patrick C.SVP Research & Development06/15/20171,616
GLAXOSMITHKLINE PLCFormer 10% Owner03/27/20173,045,180
GLAXOSMITHKLINE PLCFormer 10% Owner03/27/20173,045,180
Roche Patrick C.SVP Research & Development12/09/20161,524
McMeans Shaun DVP, Finance & Admin. & CFO12/09/20161,524
Lubniewski John LChief Business Officer12/09/20161,524
JOHNSON TIM BPresident & CEO12/09/20161,524
Gordon Debra AV.P. and Chief Legal Counsel12/09/20161,524
JOHNSON TIM BPresident & CEO06/10/20161,545
Roche Patrick C.SVP Research & Development06/10/20162,359
Lubniewski John LChief Business Officer06/10/20162,359
McMeans Shaun DVP, Finance & Admin. & CFO06/10/20162,359
Gordon Debra AV.P. and Chief Legal Counsel06/10/20162,359
Lubniewski John LChief Business Officer04/01/20162,048
Lubniewski John LChief Business Officer04/04/2016254
McMeans Shaun DVP, Finance & Admin. & CFO04/04/2016512
McMeans Shaun DVP, Finance & Admin. & CFO04/01/20164,119
JOHNSON TIM BPresident & CEO04/04/20161,573
JOHNSON TIM BPresident & CEO04/01/201612,641
Gordon Debra AV.P. and Chief Legal Counsel04/04/2016535
Gordon Debra AV.P. and Chief Legal Counsel04/01/20164,301
Roche Patrick C.SVP Research & Development03/10/20163,232
Roche Patrick C.SVP Research & Development03/14/2016243
Roche Patrick C.SVP Research & Development03/11/201610,646
McMeans Shaun DVP, Finance & Admin. & CFO03/14/2016238
McMeans Shaun DVP, Finance & Admin. & CFO03/11/201610,140
McMeans Shaun DVP, Finance & Admin. & CFO03/10/20163,081
Lubniewski John LChief Business Officer03/10/20163,765
Lubniewski John LChief Business Officer03/14/2016247
Lubniewski John LChief Business Officer03/11/201612,399
JOHNSON TIM BPresident & CEO03/14/2016273
JOHNSON TIM BPresident & CEO03/11/201619,206
JOHNSON TIM BPresident & CEO03/10/20165,832
Gordon Debra AV.P. and Chief Legal Counsel03/14/2016238
Gordon Debra AV.P. and Chief Legal Counsel03/11/20169,928
Gordon Debra AV.P. and Chief Legal Counsel03/10/20163,016
McMeans Shaun DVP, Finance & Admin. & CFO03/09/20168,933
Roche Patrick C.SVP Research & Development03/09/20169,379
Lubniewski John LChief Business Officer03/09/201610,927
JOHNSON TIM BPresident & CEO03/09/201616,924
Gordon Debra AV.P. and Chief Legal Counsel03/09/20168,748
McMeans Shaun DVP, Finance & Admin. & CFO12/10/20155,000
Gordon Debra AV.P. and Chief Legal Counsel12/10/20155,000
JOHNSON TIM BPresident & CEO12/10/201510,000
JOHNSON TIM BPresident & CEO08/24/20155,341
Gordon Debra AV.P. and Chief Legal Counsel08/24/20155,160
Roche Patrick C.SVP Research & Development08/18/201537,435
JOHNSON TIM BPresident & CEO08/12/201537,623
McMeans Shaun DVP, Finance & Admin. & CFO08/12/201578,000
Lubniewski John LChief Business Officer08/11/201538,348
Merck Capital Ventures LLC10% Owner05/11/2015775,278
Merck Capital Ventures LLC10% Owner05/11/20152,342,802
Fletcher Spaght Ventures II LP10% Owner05/11/2015620,214
Fletcher Spaght Ventures II LP10% Owner05/11/20151,434,230
GLAXOSMITHKLINE PLC10% Owner05/11/20155,111,484
Novo A/S10% Owner05/11/20155,111,484
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR HTG MOLECULAR DIAGNOSTICS INC
LOADING...